alpha-Glucosidase-IN-109 is an orally active alpha-glucosidase inhibitor with an IC50 of 0.0136 µM. alpha-Glucosidase-IN-109 modulates carbohydrate and lipid metabolism, reduces fasting blood glucose levels, alleviates weight loss, and exhibits protective effects on liver and kidney function. alpha-Glucosidase-IN-109 can be used in research related to type 2 diabetes[1].
Molekulargewicht:
322.19
Formel:
C16H13Cl2NO2
Target-Kategorie:
Glycosidase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
